
SLU-PP-3325 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
SLU-PP-332, explained simply
A compound acting on ERR receptors; the research cited so far is limited to animal models.
Research area
Preclinical metabolism
How it works
SLU-PP-332 is a synthetic compound that activates several ERR receptors associated with energy metabolism.
Why it matters
It is relevant to research on exercise adaptation and mitochondrial function.
What has been observed
Available findings on endurance and metabolism come from mouse models.
Effects and points to consider
Human clinical studies have not been identified; effects seen in mice do not establish benefits in people.
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 5 mg SLU-PP-332 |
|---|---|
| Final volume | 3 mL |
| Concentration | 1.67 mg/mL |
| One U-100 unit | 16.67 mcg in 0.01 mL |
Murine-Equivalent Protocol (3 mL = ~1.67 mg/mL)
| Phase | Daily Dose (mcg) | Per-Injection Dose (mcg) | Units per Injection (mL) |
|---|---|---|---|
| Weeks 1–2 | 1250 mcg | 625 mcg | 37.5 units (0.375 mL) |
| Weeks 3–8 | 2500 mcg | 1250 mcg | 75 units (0.75 mL) |
Supplies needed


Sterile alcohol swabs
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.